At Shorla Oncology we develop and commercialize innovative oncology drugs for women’s and pediatric cancers. We focus on indications where existing treatments are limited, in shortage or inadequate for the target population.
Our products are the result of Shorla’s world class team encompassing thought leaders, clinicians, scientists and commercial strategists who have extensive experience in the area of drug development and commercialization of niche cancer treatments.
Our growing portfolio will bring accessible, affordable and life-saving treatments to patients, delivering a major contribution to patient care and providing a significant clinical impact.
Location: Ireland
Employees: 11-50
Total raised: $43.3M
Founded date: 2018
Investors 1
| Date | Name | Website |
| 30.10.2023 | Kurma Part... | kurmapartn... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.10.2023 | Series B | $35M | - |
| 03.06.2020 | Series A | $8.3M | Seroba Lif... |
Mentions in press and media 8
| Date | Title | Description | Source |
| 03.04.2024 | From generative chemistry to computational astrophysics, sta... | Here are a few startups in the cancer space that made headlines recently The recent revelation of Pr... | vator.tv/n... |
| 20.12.2023 | Fierce Biotech Fundraising Tracker '23: Carmot spinoff Kimia... | We've launched a new Fierce Biotech Fundraising Tracker for 2023 to track all the venture capital fl... | fiercebiot... |
| 10.11.2023 | Shorla Oncology Announces US Acquisition of Jylamvo, an Onco... | October 31, 2023. Cambridge, Massachusetts and London. Shorla Oncology (‘Shorla’), a US-Ireland spec... | seroba-lif... |
| 11.10.2023 | Shorla Oncology: Specialty Pharmaceutical Company Closes $35... | Shorla Oncology – a U.S.-Ireland specialty pharmaceutical company – recently announced that it has r... | pulse2.com... |
| 05.10.2023 | Shorla Oncology Secures $35M Series B Funding Round to Advan... | Cambridge, Massachusetts, USA. 4 October 2023. Seroba’s portfolio company, Shorla Oncology (‘Shorla’... | seroba-lif... |
| 04.10.2023 | Shorla Oncology Raises $35M in Series B Funding | Shorla Oncology, a Clonmel, Ireland- and Cambridge, MA-based pharmaceutical company, raised $35M in ... | finsmes.co... |
| 07.03.2023 | Shorla Oncology Announces U.S. FDA Approval of Nelarabine In... | Cambridge, MA, USA. March 7, 2023. Shorla Oncology (‘Shorla’), a US-Ireland pharmaceutical company, ... | seroba-lif... |
| 13.04.2022 | Shorla Oncology Appoints Dennis Purcell as Chairman of the B... | Cambridge, Mass., USA. 29 March 2022. Shorla Oncology (‘Shorla’), an Irish specialty pharmaceutical ... | seroba-lif... |